Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
University Hospital, Toulouse
Samsung Medical Center
Tianjin Medical University Second Hospital
Comprehensive Cancer Center Munich (CCCM)
Dana-Farber Cancer Institute
Spanish Oncology Genito-Urinary Group
British Urology Researchers in Surgical Training
Memorial Sloan Kettering Cancer Center
University Hospital, Strasbourg, France
University Hospital, Strasbourg, France
Peking University First Hospital
Vastra Gotaland Region
Pacific Edge Limited
Fox Chase Cancer Center
Massive Bio, Inc.
Tampere University Hospital
iOMEDICO AG
University of Erlangen-Nürnberg Medical School
IRCCS San Raffaele
Hospital of Macerata
Cofactor Genomics, Inc.
UroGen Pharma Ltd.
Creative Biosciences (Guangzhou) Co., Ltd.
Fox Chase Cancer Center
National Taiwan University Hospital
IRCCS San Raffaele